Cover Image

“REDISCOVERING ARNETH COUNT” PREVALENCE OF MEGALOBLASTIC ANEMIA IN CHRONIC MET-FORMIN USERS AT GOVERNMENT STANLEY HOSPITAL,CHENNAI

R Jayanthi, T Deenadayalan

Abstract


Recent US data estimate a 6% prevalence of bio-chemical B12 deficiency (serum B12,<148 pmol/L) among adult >60 years of age who are taking metformin.Arneth count- a very simple smear test to diagnose megaloblastic anemia, is almost forgotten in modern medicine era after the ad-vent of automated analyzer. With this back-ground we want to check check the correlation between manifestations of vit B12 deficiency with duration of MF therapy and the correlation between Arneth index with MCV in diagnosis of Megaloblastic anemia. Our observation suggests that as the duration of metformin increase, de-gree of hyper segmentation of neutrophils as well as MCV tends to increase and one of the earliest, notable changes in the peripheral blood in megaloblastic processes is the appearance of hypersegmented neutrophils,so that Validity of simple Arneth count can be realized, which can be performed very easily with simple microscope in early diagnosis of megaloblastic process, which is apt even in our PHC setup.

Full Text:

PDF

References


Reinstatler L, Qi YP, Williamson RS, Garn JV,Oakley GP Jr. Association of biochemical B12deficiency with metformin therapy and vita-min B12 supplements: the National Health and Nutrition Examination Survey,1999-2006. Diabe-tes Care 2012;35:327–333

De Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12deficiency: ran-domised placebo controlled trial., BMJ 2010;340:c2181

Ting RZ, Szeto CC, Chan MH, et al. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med 2006;166:1975–1979.

Swain R: Stages of B12 deficiency. In Round Table Series 66: Vitamin B12 Deficiency. Herbert V, Ed. London, The Royal Society ofMedicine Press, 1999, p. 19–20 DIABETES

Hermann LS, Nilsson B, Wettre S. Vitamin B12 status of patients treated with metformin: a crosssectional cohort study. Br J Diabetes Vasc Dis 2004; 4:401– 6.

Filioussi K, Bonovas S, Katsaros T. Should we screen diabetic patients using biguanides for megaloblastic anaemia? Aust Fam Physician 2003;32: 383– 4.

Tomkin GH, Hadden DR, Weaver JA, Montgom-ery DA. Vitamin- B12 status of patients on long-term metformin therapy. Br Med J 1971;2:685–7.

Bell DS. Nondiabetic neuropathy in a patient with diabetes. Endocr Pract 1995;1:393– 4.

Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in patho-physiology, diagnosis and treatment. Blood Rev 2007;21:113–130

CHANARIN I: Investigation and management of megaloblastic anemia. Clin Haematol


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University